A pharmaceutical composition for the treatment of seborrhea containing 4-hydroxy-5-methoxy-4-[2-methyl-3(3-m ethyl2-butenyl)-2-oxiranyl]-1-oxaspiro[2,5]oct an-6-one

Details for Australian Patent Application No. 2002256933 (hide)

International Classifications

Event Publications

15 January 2004 Application Open to Public Inspection

Published as AU-B-2002256933

9 November 2006 Application Accepted

Published as AU-B-2002256933

8 March 2007 Standard Patent Sealed

18 June 2009 Corrigenda

Applications Accepted - Name Index Under the name Mycoplus Co., Ltd., Application No. 2002256933, under INID (43) correct the Publication Date to read 24 November 2003.

16 December 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.